SCHEMBL7961609

SCHEMBL7961609

COc1cccc(C2C=C(c3nc(-c4ccccc4)c(-c4ccccc4)o3)CCC2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.42
TDP1 Q9NUW8 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 2/20 0.42
RECQL P46063 1/20 0.42
RXRA P19793 1/20 0.41
RXRB P28702 1/20 0.41
GID4 Q8IVV7 1/20 0.39
FABP4 P15090 1/20 0.38
HPGD P15428 3/20 0.37
MAPT P10636 2/20 0.37
PTGIR P43119 5/20 0.37
PTGER4 P35408 3/20 0.37
PTGER3 P43115 1/20 0.37
RAB9A P51151 2/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7960197 0.84 PTGER4 (0.42) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL7957666 0.82 PTGER4 (0.52) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL7960392 0.82 PTGIR (0.46) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL7960009 0.78 TDP1 (0.42) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL8127073 0.72 PTGIR (0.49) KDM4ESMN1; SMN2FABP4HPGDPTGIR
SCHEMBL8065136 0.72 KDM4E (0.44) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL8074838 0.72 KDM4E (0.46) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL8066611 0.71 RXRA (0.50) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL8066704 0.71 GID4 (0.43) KDM4ETDP1SMN1; SMN2HTTLMNA
SCHEMBL8066700 0.71 GID4 (0.43) KDM4ETDP1SMN1; SMN2HTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6245790-B1 ANTIINFLAMMATORY AGENTS; GASTROINTESTINAL DISORDERS; SKN DISORDERS; BONE DISORDERS; MUSCLE RELAXANTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-06-12 US disclosed
EP-0989975-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-05 EP disclosed
WO-2000016760-A2 NEW USE OF PROSTAGLANDIN E2 ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-03-30 WO disclosed
WO-1998055468-A1 OXAZOLE COMPOUNDS USEFUL AS PGE2 AGONISTS AND ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-10 WO disclosed